Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
UBS
Express Scripts
Chubb
Fish and Richardson
Harvard Business School
Baxter
McKesson
Covington

Generated: June 18, 2018

DrugPatentWatch Database Preview

IBUPROFEN LYSINE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Ibuprofen Lysine patents expire, and when can generic versions of Ibuprofen Lysine launch?

Ibuprofen Lysine is a drug marketed by Exela Pharma Science and is included in one NDA.

The generic ingredient in IBUPROFEN LYSINE is ibuprofen lysine. There are sixty-four drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the ibuprofen lysine profile page.
Summary for IBUPROFEN LYSINE
Drug patent expirations by year for IBUPROFEN LYSINE
Pharmacology for IBUPROFEN LYSINE

US Patents and Regulatory Information for IBUPROFEN LYSINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Exela Pharma Science IBUPROFEN LYSINE ibuprofen lysine INJECTABLE;INTRAVENOUS 202402-001 Mar 30, 2016 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Cerilliant
Fish and Richardson
Accenture
US Department of Justice
McKesson
Argus Health
QuintilesIMS
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.